| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |